tibolone has been researched along with Sex Disorders in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altwerger, G; Black, J; Feinberg, J; Menderes, G; Ratner, E; Whicker, M | 1 |
| Ferriani, RA; Figueiredo, JB; Lara, LA; Martins, WP; Nastri, CO; Rosa-E-Silva, AC | 2 |
| Abad, P; Baró, F; Cancelo, MJ; Llaneza, P; Manubens, M; Mendoza, N; Quereda, F; Sánchez-Borrego, R | 1 |
| Cucinella, L; Nappi, RE | 1 |
| Birkhaeuser, MH; Davis, S; Mulder, RJ; Nathorst-Böös, J; Nijland, EA; Palacios, S; Schultz, WC; Stathopoulos, VM; van de Weijer, PW; von Mauw, E | 1 |
| Nappi, RE; Polatti, F | 1 |
| Faghihzadeh, S; Moghasemi, M; Ziaei, S | 1 |
| Basson, R; Brotto, L; van Lankveld, J; Wierman, ME | 1 |
| Cummings, S; Modelska, K | 1 |
| Basson, R; Brotto, LA; Laan, E; Redmond, G; Utian, WH | 1 |
| Giraldi, AG; Gregersen, N; Hilmand, CB; Jensen, PT | 1 |
| Burger, H; Papalia, MA | 1 |
| Albani, F; De Leonardis, C; Ferdeghini, F; Nappi, RE; Polatti, F; Salonia, A; Sampaolo, P; Vaccaro, P | 1 |
| Atasaral, T; Baltaci, D; Bozkaya, H; Osmanağaoğlu, MA | 1 |
| Giraldi, AE; Gregersen, N; Jensen, PT | 1 |
| Christov, VG; Kamenov, ZA; Todorova, MK | 1 |
| Davis, SR; Nijland, EA | 1 |
| Davis, SR; Helmond, FA; Mulder, RJ; Nathorst-Boös, J; Nijland, EA; Norman, RJ; Palacios, S; Van Lunsen, RH; Weijmar Schultz, WC | 1 |
9 review(s) available for tibolone and Sex Disorders
| Article | Year |
|---|---|
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
Topics: Administration, Topical; Anabolic Agents; Body Image; Cognitive Behavioral Therapy; Depression; Estrogen Antagonists; Estrogens; Fatigue; Female; Hormone Replacement Therapy; Humans; Lubricants; Menopause, Premature; Norpregnenes; Ovarian Neoplasms; Pelvic Floor Disorders; Physical Therapy Modalities; Phytotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sexuality; Tamoxifen; Testosterone | 2017 |
Hormone therapy for sexual function in perimenopausal and postmenopausal women.
Topics: Drug Therapy, Combination; Estrogens; Female; Humans; Indoles; Middle Aged; Norpregnenes; Perimenopause; Postmenopause; Progesterone; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological | 2013 |
Hormone therapy for female sexual function during perimenopause and postmenopause: a Cochrane review.
Topics: Databases, Factual; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Norpregnenes; Perimenopause; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological | 2014 |
Advances in pharmacotherapy for treating female sexual dysfunction.
Topics: Buspirone; Clinical Trials, Phase III as Topic; Estrogens; Female; Humans; Menopause; Norpregnenes; Piperazines; Purines; Selective Estrogen Receptor Modulators; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfonamides; Tamoxifen; Testosterone | 2015 |
Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials.
Topics: Adult; Androgens; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; MEDLINE; Middle Aged; Norpregnenes; Piperazines; Placebos; Postmenopause; Purines; Randomized Controlled Trials as Topic; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones | 2003 |
[Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
Topics: Adult; Androgens; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Incidence; Libido; Menopause; Middle Aged; Norpregnenes; Phosphodiesterase Inhibitors; Piperazines; Postmenopause; Purines; Risk Factors; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Testosterone | 2006 |
Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate.
Topics: Androgens; Dehydroepiandrosterone; Female; Humans; Libido; Norpregnenes; Sexual Dysfunction, Physiological; Testosterone | 2006 |
Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Androgen Antagonists; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Middle Aged; Norpregnenes; Perimenopause; Piperazines; Purines; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Testosterone; Vagina | 2006 |
Pharmacological therapy for female sexual dysfunction: has progress been made?
Topics: Anabolic Agents; Androgens; Estrogens; Female; Humans; Norpregnenes; Phosphodiesterase Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone | 2008 |
6 trial(s) available for tibolone and Sex Disorders
| Article | Year |
|---|---|
Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.
Topics: Administration, Cutaneous; Aged; Breast; Double-Blind Method; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pain; Postmenopause; Sexual Dysfunction, Physiological; Uterine Hemorrhage | 2009 |
Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Topics: Cluster Analysis; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Libido; Middle Aged; Norpregnenes; Orgasm; Postmenopause; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome | 2010 |
Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy.
Topics: Clitoris; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Pilot Projects; Postmenopause; Regional Blood Flow; Sexual Dysfunction, Physiological; Treatment Outcome | 2006 |
Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
Topics: Arousal; Coitus; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hormone Antagonists; Humans; Libido; Middle Aged; Nandrolone; Norpregnenes; Patient Satisfaction; Postmenopause; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Single-Blind Method; Treatment Outcome | 2006 |
Effect of tibolone on sexual function in late postmenopausal women.
Topics: Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Sexual Dysfunction, Physiological; Surveys and Questionnaires | 2007 |
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Sexual Dysfunction, Physiological; Stress, Psychological | 2008 |
4 other study(ies) available for tibolone and Sex Disorders
| Article | Year |
|---|---|
Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
Topics: Aged; Bone Density; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Sexual Dysfunction, Physiological; Societies, Medical; Spain | 2013 |
The use of estrogen therapy in women's sexual functioning (CME).
Topics: Administration, Cutaneous; Aged; Atrophy; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norpregnenes; Sexual Dysfunction, Physiological; Vagina; Vasoconstriction | 2009 |
Summary of the recommendations on sexual dysfunctions in women.
Topics: Adjuvants, Immunologic; Dehydroepiandrosterone; Diagnostic and Statistical Manual of Mental Disorders; Dyspareunia; Estrogen Receptor Modulators; Estrogens; Female; Guidelines as Topic; Humans; Libido; Norpregnenes; Physical Examination; Psychology; Severity of Illness Index; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Vaginismus | 2010 |
Assessment and management of women's sexual dysfunctions: problematic desire and arousal.
Topics: Adult; Androgens; Bupropion; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Estrogen Receptor Modulators; Estrogens; Female; Humans; Libido; Norpregnenes; Prevalence; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2005 |